All Stories

  1. Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency
  2. Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2
  3. Let-7 microRNA as a potential therapeutic target with implications for immunotherapy
  4. acn-1, a C. elegans homologue of ACE, genetically interacts with the let-7 microRNA and other heterochronic genes
  5. RACK-1 regulateslet-7microRNA expression and terminal cell differentiation inCaenorhabditis elegans
  6. Extensive sequence variation in the 3′ untranslated region of theKRASgene in lung and ovarian cancer cases
  7. Autoregulation oflin-4microRNA transcription by RNA activation (RNAa) inC. elegans
  8. In this issue ofEpigenetics
  9. RNA-mediated gene activation
  10. MicroRNAs and the Genetic Network in Aging
  11. Canonical and Non-Canonical Barriers Facing AntimiR Cancer Therapeutics
  12. Anthranilate Fluorescence Marks a Calcium-Propagated Necrotic Wave That Promotes Organismal Death in C. elegans
  13. MicroRNAs in the ionizing radiation response and in radiotherapy
  14. MicroRNAs circulate around Alzheimer's disease
  15. Ageing and the small, non-coding RNA world
  16. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications
  17. The multiple roles of microRNA-155 in oncogenesis
  18. FGF Regulates TGF-β Signaling and Endothelial-to-Mesenchymal Transition via Control of let-7 miRNA Expression
  19. Novel MicroRNAs Differentially Expressed during Aging in the Mouse Brain
  20. Biases and Errors on Allele Frequency Estimation and Disease Association Tests of Next‐Generation Sequencing of Pooled Samples
  21. The Duality of OncomiR Addiction in the Maintenance and Treatment of Cancer
  22. Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
  23. MiR-33 connects cholesterol to the cell cycle
  24. A 'pivotal' new rule for microRNA-mRNA interactions
  25. KRAS alleles: The LCS6 3′UTR variant and KRAS coding sequence mutations in the NCI-60 panel
  26. Cigarette-Smoke-Induced Dysregulation of MicroRNA Expression and Its Role in Lung Carcinogenesis
  27. Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC
  28. MicroRNAs in Mutagenesis, Genomic Instability, and DNA Repair
  29. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
  30. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells
  31. MicroRNA Predictors of Longevity in Caenorhabditis elegans
  32. Prevention of K-Ras- and Pten-mediated intravaginal tumors by treatment with camptothecin-loaded PLGA nanoparticles
  33. Association between KRAS rs61764370 and triple-negative breast cancer—a false positive? – Authors' reply
  34. The POU transcription factor UNC‐86 controls the timing and ventral guidance of Caenorhabditis elegans axon growth
  35. Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
  36. MicroRNA signatures differentiate melanoma subtypes
  37. MicroRNA therapeutics in preclinical cancer models
  38. A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
  39. Analysis of microRNA Expression and Function
  40. kin-19/casein kinase Iαhas dual functions in regulating asymmetric division and terminal differentiation inC. elegansepidermal stem cells
  41. MicroRNAs Both Promote and Antagonize Longevity in C. elegans
  42. Micrornas in Development and Cancer
  43. Single Nucleotide Polymorphisms in MicroRNAs and MicroRNA Binding Sites with Roles in Cancer
  44. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
  45. A Developmental Timing Switch Promotes Axon Outgrowth Independent of Known Guidance Receptors
  46. The nuclear receptor gene nhr-25 plays multiple roles in the Caenorhabditis elegans heterochronic gene network to control the larva-to-adult transition
  47. MicroRNAs and Cancer: A meeting summary of the eponymous Keystone Conference
  48. Big roles for small RNAs
  49. Developmental biomarkers of aging in Caenorhabditis elegans
  50. Robust and specific inhibition of microRNAs in Caenorhabditis elegans
  51. C. elegans sym-1is a downstream target of the Hunchback-like-1 developmental timing transcription factor
  52. Ribosomal protein RPS-14 modulates let-7 microRNA function in Caenorhabditis elegans
  53. Transcription of the C. elegans let-7 microRNA is temporally regulated by one of its targets, hbl-1
  54. RNAi and microRNA-oriented therapy in cancer: rationales, promises and challenges
  55. An interview with Dr. Frank Slack on his highly cited paper published inCell Cycle
  56. The microRNAs of Caenorhabditis elegans
  57. An elegant miRror: microRNAs in stem cells, developmental timing and cancer
  58. Inhibiting microRNA function in vivo
  59. Transcriptional control of microRNA expression inC. elegans: Promoting better understanding
  60. Dynamic expression of small non-coding RNAs, including novel microRNAs and piRNAs/21U-RNAs, during Caenorhabditis elegans development
  61. MicroRNA in Cancer Prognosis
  62. The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse embryonic survival and neural tube closure
  63. Epstein-Barr virus-mediated dysregulation of human microRNA expression
  64. A truth serum for cancer — microRNAs have major potential as cancer biomarkers
  65. The let-7 family of microRNAs
  66. The let-7 microRNA interfaces extensively with the translation machinery to regulate cell differentiation
  67. let-7 microRNAs in development, stem cells and cancer
  68. MicroRNAs and cancer: An overview
  69. miRNA modulation of the cellular stress response
  70. Thelet-7microRNA reduces tumor growth in mouse models of lung cancer
  71. Small non-coding RNAs in animal development
  72. The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans
  73. microRNAs: small molecules with big roles –C. elegans to human cancer
  74. Transcriptional (dys)regulation and aging in Caenorhabditis elegans
  75. And Now Introducing Mammalian Mirtrons
  76. The Caenorhabditis elegans pumilio homolog, puf-9, is required for the 3′UTR-mediated repression of the let-7 microRNA target gene, hbl-1
  77. The evolution of animal microRNA function
  78. microRNA-Mediated Silencing Inside P Bodies
  79. microRNA Control of Lifespan and Metabolism
  80. Micromanagement: A Role for MicroRNAs in mRNA Stability
  81. Oncomirs — microRNAs with a role in cancer
  82. MicroRNAs as a potential magic bullet in cancer
  83. Reciprocal expression of lin‐41 and the microRNAs let‐7 and mir‐125 during mouse embryogenesis
  84. RAS Is Regulated by the let-7 MicroRNA Family
  85. The Temporal Patterning MicroRNA let-7 Regulates Several Transcription Factors at the Larval to Adult Transition in C. elegans
  86. Developmental Timing in C. elegans Is Regulated by kin-20 and tim-1, Homologs of Core Circadian Clock Genes
  87. The age of high-throughput microRNA profiling
  88. The Silent Revolution
  89. The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter
  90. The C. elegans hunchback Homolog, hbl-1, Controls Temporal Patterning and Is a Probable MicroRNA Target
  91. siRNA
  92. Control of developmental timing by small temporal RNAs: a paradigm for RNA‐mediated regulation of gene expression
  93. The lin-41 RBCC Gene Acts in the C. elegans Heterochronic Pathway between the let-7 Regulatory RNA and the LIN-29 Transcription Factor
  94. Expression and Function of Members of a Divergent Nuclear Receptor Family in Caenorhabditis elegans
  95. Heterochronic Genes in Development and Evolution
  96. A novel repeat domain that is often associated with RING finger and B-box motifs
  97. TEMPORAL PATTERN FORMATION BY HETEROCHRONIC GENES
  98. A gene required for nutritional repression of the Bacillus subtilis dipeptide permease operon